AI-Based Computational Pathology

AI-Based Computational Pathology

In the industry news, IeB showcases its analytical viewpoint on transformative cloud-based technology, which aligns with a company’s future growth initiatives. It entails a holistic impact across the organization, its end-users, and peer industry participants. Furthermore, it will also represent the shifting trends across the industry ecosystem.

Strategic Development

Modern equipment used for biological imaging is expensive and is located in specialized laboratories. Which requires highly qualified staff. There are newer at point similar products to research novel, creative approaches and to address urgent scientific issues. Such as AI-based Computational pathology. Using a digital microscope and scanner. It is one of the most promising markets It helps in reducing the cost and increasing the accuracy of the report thus Uplifting the overall diagnosis market. The product also solves issues such as the shortage of experienced pathologists and the limitation of healthcare resources.

Strategic Alignment

Crosscope and KFBIO join forces to lead digital transformation for pathology in India and emerging markets. KFBIO which is an innovative Whole slide imaging pathology scanner manufacturing is partnering with Crosscope an AI Company. To cater AI AI-based diagnosis equipment at a fraction of the price.

Immediate Impact

Developing countries with growing populations have a huge opportunity to cater to patients and have quality results at a faster pace. Thus, a large number of pathology reports can be processed in less time.

Budding Growth Opportunities for End-Users

Collaboration between Crosscope and KFBIO will ensure the wide range & state-of-the-art Whole Slide Imaging Digital Pathology scanners are made available to the Indian market and ensure this cutting-edge technology is available for the pathology community to enable digital transformation in the pathology laboratories in India & emerging markets.

Potential Advancements for Peer Markets

MedTech start-ups in India one of such is Morphle Digital Pathology. They are offering a robotic plug-and-play whole slide scanner Technology that provides superior image quality, quick scanning, and image analysis tools that can analyze. These devices can provide high-quality images for samples. The image generated can be quickly shared through software thus fast pacing the diagnosis.

Shifting Industry Trends

The Pathologies working with such new techs will have a better and more accurate report with an exceptional rate of fast delivery of reports. Many diseases such as cancer and flu that require quick results can be dealt with quickly. The AI-based pathology images and reports can help a lot to accurately predict the disease. Thus, this technology will have a bigger market in the future it can help in reducing labor hours and critical human errors. As well the machine can be maintained remotely.

our Experts